3.0
Jul 10, 2009
Current employee
Recommend
CEO approval
Business outlook
Pros
Roche is relatively stable for the next few years (no major patent expiration looming), so there is some degree of job security.
Cons
There are so many changes going on that are creating an uncertain environment at Palo Alto as well as Genetech.